In one cohort undergoing low-dose CT screening for LC, LC was detected in 2.5% of patients, ILA affecting >5% of the lung were detected in 4.2%, and 1.51% of patients met the criteria for ILD.(50). This evidence concerns the gene TNFRSF9 and laryngotracheoesophageal cleft.